Heart failure remains a major public health concern with a 5-year mortality rate higher than that of most cancers. Myocardial disease in heart failure is frequently accompanied by impairment of the specialized electrical conduction system and myocardium. We introduce an epicardial mesh made of electrically conductive and mechanically elastic material, to resemble the innate cardiac tissue and confer cardiac conduction system function, to enable electromechanical cardioplasty. Our epicardium-like substrate mechanically integrated with the heart and acted as a structural element of cardiac chambers. The epicardial device was designed with elastic properties nearly identical to the epicardial tissue itself and was able to detect electrical signals reliably on the moving rat heart without impeding diastolic function 8 weeks after induced myocardial infarction. Synchronized electrical stimulation over the ventricles by the epicardial mesh with the high conductivity of 11,210 S/cm shortened total ventricular activation time, reduced inherent wall stress, and improved several measures of systolic function including increases of 51% in fractional shortening,~90% in radial strain, and 42% in contractility. The epicardial mesh was also capable of delivering an electrical shock to terminate a ventricular tachyarrhythmia in rodents. Electromechanical cardioplasty using an epicardial mesh is a new pathway toward reconstruction of the cardiac tissue and its specialized functions.
INTRODUCTION
The heart efficiently pumps blood by coordinated contractions made by the rapid conduction of electrical impulses. Heart failure is often accompanied by impairment of, or injury to, the specialized HisPurkinje conduction system (1) . Currently, patients undergo medical therapy in an attempt to reverse adverse mechanical remodeling.
Biventricular pacing attempts to improve electrical dyssynchrony but can only be applied to a subset of patients and has a significant nonresponder rate associated with it. Thus, a comprehensive approach that partially compensates for impaired myocardium and substitutes for functions of the diseased electrical conduction system would be a promising treatment for heart failure patients.
Biventricular pacing, for which a subset of heart failure patients may qualify, has been proven to rapidly enhance cardiac function, alleviate symptoms, and improve long-term survival in numerous clinical trials (2) . This type of pacing improves inefficient pumping activity by reducing the discoordination of contractions in diseased hearts by simultaneously pacing both chambers. Therefore, it has been proposed as a standard therapy by the American College of Cardiology and the American Heart Association in the subset of patients who may benefit (3) . Despite these positive attributes, biventricular pacing involves the activation of the myocardium through electrical current sources originating from only two point electrodes located in the dilated ventricle, rather than a more comprehensive approach where large areas of the myocardium are activated simultaneously.
The concept of cardiomyoplasty, augmenting the function of diseased myocardium through a biventricular wrap, was introduced in the 1980s and involved wrapping the skeletal muscle (latissimus dorsi) around the heart to prevent postmyocardial infarction (post-MI) remodeling and to augment systolic function by pacing skeletal muscle flap (4) . Unfortunately, this initially attractive therapy faded from clinical practice because hemodynamic improvement in systolic function was not consistently demonstrated, and sudden death and arrhythmic events occurred during follow-up. Instead, a device encircling the heart was hypothesized to act as a structural subcomponent of myocardium to share myofiber stress as well as reduce the size of cardiac chambers thereby contributing to a positive remodeling process and subsequent improvement of pumping activity (5) (6) (7) . Human trials using devices wrapping the heart, such as the electrically nonconductive polyester mesh wrap CorCap (Acorn Cardiovascular Inc.) and the nitinol mesh wrap HeartNet (Paracor Medical Inc.), also showed controversial results. In a randomized clinical trial, HeartNet wrapping the heart in patients with heart failure had no effect on functional end points, particularly peak oxygen consumption or survival (5) . The CorCap trial did demonstrate significant improvement in the prevention of ventricular remodeling, but there were controversial results in long-term survival (6, 7) .
Here, we introduce electromechanical cardioplasty using an epicardial mesh designed to both mechanically integrate with the heart and act as a structural element of cardiac chambers, enabling global pacing to stimulate the whole ventricle. We also instilled the electrical function of a cardiac conduction system (His bundles and Purkinje fiber network) into the mesh to deliver impulses to the whole ventricular myocardium in concert, rather than merely to small point electrodes in the ventricles. To achieve these, we explored candidate materials to be elastic and conductive as in cardiac tissue. Recently developed conductive and stretchable materials, such as gold-based composites (8, 9) and carbon nanotube-based composites (10, 11) , have shown potential as elasto-conductive materials. However, many technical issues, including low conductivity, poor elasticity, and/or high resistance change induced by strains, still remain. Meanwhile, silver nanowire (AgNW) networks are known to maintain high conductivity under repeatedly applied strains due to their mechanical deformability and highly percolated structures (12, 13) . Styrene-butadiene-styrene (SBS) rubber, a biocompatible thermoplastic polymer, has high elasticity and reshaping capability because of its physically cross-linked structure (14, 15) . We chose AgNW and SBS rubber to fabricate the mesh-shaped substrate resembling elastic and electrical properties of cardiac tissue.
In postinfarct rats, the epicardial mesh integrated with the heart preserved diastolic relaxation, reduced inherent wall stress by sharing cardiac load as a structural component, improved cardiac contractile function through synchronized electrical stimulation, and terminated ventricular tachyarrhythmia as an epicardial defibrillator. Our study demonstrates an improved therapeutic approach to electromechanical cardioplasty using an epicardial device that reconstructs the cardiac tissue form and its specialized functions.
RESULTS
The epicardial mesh is soft, elastic, and highly conductive The cardiac conduction system spreads across the endocardial surface of the ventricles and rapidly transmits electrical signals from endocardium to epicardium by interfacing directly with cardiac muscles to enable coordinated contractions of the heart. For the elasto-conductive mesh device design, we attempted to imitate the basic structure and function of the heart (Fig. 1A) . To confer elasticity and stable electrical conductivity, we fabricated a homogeneous nanocomposite of AgNW and SBS rubber. Ligand exchange of AgNW (LE-AgNW) is necessary for homogeneous dispersion in the organic-phase SBS solution (15) (16) (17) . Polyvinylpyrrolidone (PVP) ligand of AgNW was partially exchanged to hexylamine (HAm) using NOBF 4 (Fig. 1B) , allowing for a phase transfer of the water-dispersed AgNW to the organic phase. The increased peak intensity of N-H bond stretching in the Fourier transform infrared spectroscopy spectra confirmed successful ligand exchange reaction (fig. S1A). Compared to AgNW/SBS nanocomposite without ligand exchange, LE-AgNW/SBS nanocomposite exhibited consistently lower impedance for different frequency inputs (Fig. 1C ) and larger charge injection for different voltage inputs (Fig. 1D) , indicating stable electrical conduction of the LE-AgNW/SBS nanocomposite. The conductivity of LE-AgNW/SBS nanocomposite also depended on the mixing ratio of LE-AgNW to SBS ( fig. S1B ). As the proportion of LE-AgNW increased, electrical conductivity improved, but mechanical elasticity was deteriorated ( fig. S1C) , demonstrating that the optimal ratio of LE-AgNW and SBS is required to achieve both good electrical conductivity and elasticity. A nanocomposite with LE-AgNW/SBS ratio of 65:35 conferred the optimal conductivity of 11,210 S/cm, which is 1000-fold higher than conventional commercial conductive rubber (<10 S/cm).
Next, we optimized the elastic properties of the LE-AgNW/SBS nanocomposite. Encircling the heart with a stiff film may decrease diastolic compliance, thereby aggravating heart failure symptoms, as shown in cardiac diseases such as constrictive pericarditis or restrictive cardiomyopathy (18) . Therefore, we aimed to create a device with mechanical properties similar to that of the rat myocardium to conform anatomically to and integrate with the epicardial surface. To tailor mechanical elasticity of the LE-AgNW/SBS nanocomposite, a mesh design was applied using a polydimethylsiloxane (PDMS) mold ( Fig. 1E and fig. S2 ). To improve durability, the LE-AgNW/SBS nanocomposite was covered by an SBS layer. The elastic modulus was 44.71 ± 7.54 kPa in serpentine mesh and 3.39 ± 0.849 kPa in hyperserpentine mesh, depending on the extent of curvature of the serpentine structure. The serpentine and hyperserpentine meshes exhibited remarkably softer mechanical properties than the film of the same material (Fig. 1F) .
We then resected epicardial tissue sheets from rat hearts and measured the elastic modulus of 2-mm-thick epicardial tissue sheets, which was 34.67 ± 6.2 kPa (n = 3). The circumferential strain (change of circumference between end diastole and end systole divided by circumference at end diastole) in the outer layer of the heart estimated by echocardiography was 14.1 ± 1.4% in control hearts (n = 4) and 4.6 ± 0.5% in 8-week post-MI rat hearts (n = 3) (Fig. 1G) . On the basis of these results, we chose a serpentine mesh design with elasticity nearly identical to that of epicardium within a physiological strain range of 20% in cardiac movement. Under these applied strains, the epicardial mesh exhibited minimal change in its electrical resistance (Fig. 1H) . The electrical property was consistent with only 1.02-fold increase over 10,000 repetitive stretching cycles, approximating 3 hours of cardiac movement in humans (Fig. 1H, inset) .
Personalized design is made using a 3D printed heart The epicardial mesh was designed as shown in Fig. 2A . The size of the electrodes was large enough to cover the entire ventricles [right ventricle (RV), 12.5 × 10 mm; left ventricle (LV), 17 × 10 mm; thickness, 100 mm]. This design enabled the current flow by electrical stimulation to be broadly distributed, allowing rapid propagation of depolarization of the myocardium as shown in the previous reports (19, 20) . The device was composed of two wide serpentine mesh electrodes, which were positioned on the RV and the LV, with an insulating part between the cathode and anode (denoted as I) and supporting parts at the ends (denoted as S) to assist wrapping of the device around the heart (Fig. 2A) . The mass of silver was about 20 mg per device.
The outer part of the epicardial mesh was coated with an SBS to insulate the electrodes ( Fig. 2A, right) . The elasticity of the device was confirmed by pulling (L 0 = 60 mm to L 1 = 90 mm) and releasing the mesh (L 1 to L 0 ′= 60 mm) ( Fig. 2B and movie S1 ). Using a 3D image created by cardiac computed tomography (CT) (Fig. 2C) , we could make an anatomically personalized design for the rodents. The final design was confirmed by wrapping a 3D printed heart model with the mesh tailored to the rat's cardiac parameters, including the size of each part (RV, LV, I, and S) and the overall size measured at systole (Fig. 2D) .
Computer simulations estimate the mechanical effect of the epicardial mesh We estimated the mechanical effects of the epicardial mesh on rat heart diastolic function through a biventricular finite element model constructed from high-resolution CT images, with continuous transmural fiber orientations across its thickness (Fig. 3A) . Diastolic expansions of three cases on the wrapping model ( Fig. 3B) were compared: (i) without any wrap on the heart, (ii) with the wrap using epicardial mesh (E = 50 kPa), and (iii) with the wrap of unpatterned device (continuous thin film; E = 47 MPa). The effects of the epicardial mesh or film wrap on end-diastolic pressure-volume relationship were analyzed (Fig. 3C ). Compared to the control (no wrapping), the film wrap constrained heart inflation and elevated end-diastolic pressure, possibly leading to increased backward pressure to the left atrium and pulmonary vascular congestion. In contrast, the epicardial mesh wrap did not show any appreciable effect. Notably, the film of the LE-AgNW/SBS nanocomposite caused diastolic collapse in the RV in silico (Fig. 3D) , implying a significant risk of hemodynamic instability. In contrast, the epicardial mesh wrap did not affect the shape or curvature of ventricular chambers during the simulated cardiac cycle.
The epicardial mesh integrates with the moving rat heart without impeding diastolic relaxation We tested whether the epicardial mesh maintained conformal contacts on the moving heart in vivo and consistently monitored intrinsic myocardial electrical activities. A custom-designed epicardial mesh covering the entire surface of both ventricles was implanted in a control rat (Fig. 4A) . Baseline surface electrocardiogram (ECG), conventional bipolar electrode, and epicardial mesh simultaneously detected cardiac electrical activity (Fig. 4B ). Phase consistency of the whole electrograms and the severity of the baseline drift were compared between a conventional bipolar electrode and an epicardial mesh. Electrograms recorded from the epicardial mesh exhibited stable signals without any visible baseline drifts, whereas baseline drift was evident in electrograms from the conventional bipolar electrode with a 2-mm interval placed on the RV surface (Fig. 4, B and C) . After subtracting QRS-T complexes, average absolute deviation of the baseline drift was significantly less with the epicardial mesh than with the conventional electrode (Fig. 4D) , suggesting that the epicardial mesh was well integrated to the epicardial surface of the moving heart.
Next, we tested the influence of the epicardial mesh with elastic properties on diastolic relaxation and myocardial stress. One desirable effect was to reduce stress of the host myocardium by sharing it with the introduced device without disturbing diastolic relaxation. MI is the most common cause of human heart failure, and thereby, we induced an MI in 36 rats (19 survived by 8 weeks after MI) in this test. Areas of scar in the post-MI model created by left anterior descending artery (LAD) ligation were confirmed histologically using Masson's trichrome stain or by gross specimen examination in all survived rats.
The effect of the epicardial mesh on diastolic function was evaluated at baseline and during right atrial pacing and mesh pacing at the same cycle length of 420, 300, and 280 ms in control (n = 5) and 8-week post-MI rats (n = 5), because diastolic relaxation is influenced by heart rate. The implanted epicardial mesh did not significantly change the LV enddiastolic pressure (LVEDP), an index of compliance, or t, an index of diastolic relaxation at baseline (sinus rhythm) and during electrical stimulation in the control and post-MI rats (all P > 0.05 by linear mixed model; Fig. 5A ). Furthermore, we did not observe a constrictive pattern of LV pressure in all experimental rat hearts (Fig. 5B) .
Mechanical stress on the myocardium exerts tension on cardiomyocytes, stimulating various pathophysiologic responses (21) . We sought to investigate the impact of the epicardial mesh as a structural component on myocardial stress. To measure changes in wall stress, we recorded LV pressure with a Millar catheter and simultaneously measured mid-LV radial strain by echocardiography. During the electrical stimulation with the epicardial mesh, longitudinal wall stress was reduced during the entire cardiac cycle (diastole and systole) in the post-MI heart and slightly reduced in the control (Fig.  5C) . In post-MI hearts, the epicardial mesh reduced the peak longitudinal wall stress of 654.6 kdyne/cm 2 at baseline to 569.1 kdyne/cm 2 . During the overall time of systole, the average of wall stress reduction by the epicardial mesh was 46.9 kdyne/cm 2 . During the overall time of diastole, wall stress was 12.0 kdyne/cm 2 .
Electrical stimulation restores total ventricular activation time and improves systolic function We investigated whether electrical stimulation by the epicardial mesh could substitute the basic function of HisPurkinje fibers by shortening total activation time of the ventricles (QRS duration) and activating heart muscles synchronously. The mean QRS duration at baseline in 8-week post-MI rats was significantly more prolonged than in controls ( fig. S3A ), reflecting damages to myocardium and/or the conduction system due to underlying disease. Whole-ventricle pacing at a cycle length of 280 ms was then continuously delivered through the epicardial mesh in control and post-MI rats ( fig. S3B ). In controls, the duration of the QRS complex during epicardial mesh pacing (26.5 ± 0.7 ms) was nearly identical to that at baseline (28.6 ± 0.7 ms) (Fig. 6, A and B, and fig. S3A ). The total activation time by the epicardial mesh pacing approximates the healthy His-Purkinje conduction system. Epicardial mesh pacing in post-MI hearts resulted in a QRS duration similar to that observed in control hearts during sinus rhythm or epicardial mesh pacing, reducing the QRS duration from 38.9 ± 3.6 ms at baseline to a normal range of 26.1 ± 3.0 ms ( fig. S3A ). Figure 4B also demonstrates reduction of QRS duration by mesh pacing in all post-MI rats.
All post-MI rats that completed the electrophysiology study showed the effective normalization of QRS duration (≤27 ms) by epicardial mesh pacing, except for one animal where QRS duration was reduced from 66 to 37 ms. To evaluate the possibility that QRS duration varied with heart rate, we measured the QRS duration at multiple heart rates in all rats. We found that heart rates were unrelated to QRS duration ( fig. S4A ). We also found that epicardial mesh pacing at 90% of the baseline cycle length (10% faster than the native heart rate) shortened the QRS duration compared to the nonpaced, native QRS duration at baseline ( fig. S4B ), but this was tested only in two of the animals from Fig. 6B (that had the cycle lengths of mesh pacing similar to that of baseline) and would need further exploration. These data suggest that electrical stimulation therapy with the epicardial mesh in an 8-week post-MI heart restores overall electrical activation time of the ventricles to near-normal activation time.
To assess mechanical synchrony of the myocardium, radial strains were observed at all six mid-LV segments in control and post-MI hearts using speckle tracking imaging ( fig. S5, A and B) . Examples of speckle tracking of strain are shown in fig. S5A for baseline (sinus rhythm) and RV pacing (a positive control showing dyssynchrony, only for visual demonstration of the method here) and mesh pacing (synchrony). These images were quantified at various points (color coded in fig. S5A ) and revealed that dyssynchronous systolic contractions were present in the post-MI rats ( fig. S5B ). However, electrical stimulation through the epicardial mesh restored synchronous activation of all segments, which agrees with the shortening of the total electrical activation time of ventricles.
We further assessed whether electrical stimulation by the epicardial mesh led to the improvement of cardiac pump functions. In 2D echocardiography, post-MI rats exhibited impaired LV systolic function [percent fractional shortening (FS)] and enlarged LV end-systolic diameter (LVESD) compared to the controls at baseline (Fig. 6C ). Electrical stimulations with the epicardial mesh significantly reduced the LVESD and increased FS by 51% in post-MI rats (to 33.3 ± 1.98%) but did not restore FS to average control levels of 52% (table S1). To investigate how electrical stimulation contributes to overall improvement of cardiac pumping functions, we measured peak radial strain of individual segments of the LV chamber wall during electrical stimulation by the epicardial mesh. In control rats, myocardial strain of six LV segments was unchanged by epicardial mesh pacing at a cycle length of 280 ms (Fig. 6D and table S2 ). In post-MI rats, depressed strains of each LV segment were significantly improved by electrical stimulations at the cycle length of 280 ms (Fig. 6D and  table S2 ). Contractility (dP/dt max ) was also improved by the epicardial mesh pacing compared to right atrial pacing (Fig. 6E and table  S3 ). These data indicate that electrical stimulation through the epicardial mesh improves systolic function and contractility by increasing myocardial strain of individual segments as well as synchronous activity.
Last, the epicardial mesh demonstrated the capability to detect and terminate abnormal electrical activities such as ventricular tachycardia and ventricular fibrillation, both of which occurred spontaneously in the post-MI heart (Fig. 6, F and G) . A biphasic electrical shock of 2 J delivered through the epicardial mesh successfully terminated ventricular fibrillation, demonstrating its potential use for both pacing and defibrillation in a future clinical setting.
Biocompatibility of the epicardial mesh and alternative gold-passivated mesh Before translation, we tested the cellular toxicity and inflammatory reaction of the LE-AgNW/SBS. The ratio of 65:35 of LE-AgNW/SBS revealed minimal adverse reaction in human acute monocytic leukemia cells (THP-1), human umbilical vein endothelial cells (HUVEC), human lung carcinoma cells (A549), and rat myoblasts (H9C2), whereas the 90:10 formulation significantly reduced cell viability in these cell lines ( fig. S6A ). The mesh made of LE-AgNW/SBS (63:35 ratio) was then implanted in one rat heart and in the skeletal muscles of three rats (abdominal rectus muscle in two rats and femoral muscle in one rat; Fig.  7B and fig. S6, B and C) . Histology 3 weeks after implant revealed relatively minimal inflammatory infiltrates ( fig. S6D) .
We also looked into gold-coated LE-AgNW/SBS meshes that might be more desirable in humans, owing to inherent inert properties (22) . Therefore, we passivated the surface of LE-AgNW/SBS with a gold thin film deposited by thermal evaporation (Fig. 7A) . Inductively coupled plasma mass spectrometry analysis showed that silver ions did not leach out from the gold-coated mesh, but not more so than the regular mesh ( fig. S7A ). The cytotoxicity test demonstrated better biocompatibility in the Au-coated mesh than in the bare LE-AgNW/SBS mesh in three different cell lines in vitro: A549, HUVEC, and a mouse cardiac muscle cell line, HL-1 ( fig. S7B ). Hematoxylin and eosin staining and macrophage assay of a rat skeletal muscle also revealed less inflammatory infiltrate in the Au-coated LE-AgNW/SBS mesh ( Fig. 7B  and fig. S7C ). Furthermore, the electrical properties of the Au-coated LE-AgNW/SBS mesh were the same as those of the LE-AgNW/SBS mesh under mechanical deformation (Fig. 7C) ; thus, the Au-coated LE-AgNW/SBS mesh exhibited clear cardiac electrical activity in control rat in vivo ( fig. S7D ).
DISCUSSION
Here, we introduce an elasto-conductive electrode composed of a silver nanowire-polymer (LE-AgNW/SBS) nanocomposite that is able to conform to the rodent heart and deliver electrical impulses to restore function after MI. The 1D structure of metal nanowires formed a highly conducting electrical network, whereas the SBS rubber acted as a binder to maintain the mechanical elasticity. Electromechanical cardioplasty using the elasto-conductive epicardial mesh improved systolic function by acting as a global epicardial pacemaker to activate the entire ventricular myocardium simultaneously and reduced host myocardial wall stress by acting as a structural component but did not impede ventricular relaxations. All these effects improved cardiac pumping functions in a rodent MI model.
In diseased myocardium, abnormal electrical conduction occurs as a result of impaired muscle-to-muscle conduction as well as disruption to Purkinje fibers. Biventricular pacing was designed to reduce the discoordination of contraction in diseased hearts. However, electrical stimulation by only two point electrodes on both ventricles may be too localized to completely restore the global synchronous contractions. Therefore, we sought to make an artificial Purkinje fiber-like system encircling the outer shell of the heart to maximize synchronous contraction, similar to the mesh-like endocardial Purkinje system in the human ventricles. We also incorporated a defibrillation function to abort sudden death from ventricular arrhythmias. Such device represents a major improvement on the goal of resynchronization, because it restores native activation times and could not be limited by coronary sinus venous anatomy, native QRS width, or LV scar. Furthermore, the potential candidates eligible for biventricular pacing therapy are estimated to be less than 25% of heart failure patients, and only one in four of these potential candidates receives this therapy in an actual clinical practice (23) . We believe that electromechanical cardioplasty using an epicardial mesh holds promise for these patients. Two similar heart wraps have been tested in people. Our electromechanical cardioplasty by electrically conductive device consistently improved systolic function in all individual rats, whereas clinical data on cardiac restraint devices and cardiomyoplasty using skeletal muscle showed inconsistent results. However, we would need to investigate this consistency for longer periods of time in the animals and also test in larger animals with spontaneous arrhythmias to comment on survival and prevention of arrhythmic events. For future clinical applications, a percutaneous or surgical technique to gain access to the pericardial space and deploy the cardiac mesh safely and effectively in humans must be developed.
Another advantage of our device is the ability to confer the functions of a structural component on the diseased heart. The elasticity of the epicardial mesh is almost identical to the epicardium, enabling integration with the heart. Tissue engineering, such as cardiac slice transplantation, aims to boost contractile function and reduce stress of the host myocardium by sharing cardiac load with the introduced tissue. However, transplanted cell sheets composed of rat neonatal cardiomyocytes have demonstrated poor survival in rat hearts (14% survival of transplanted cells in infarcted hearts) (24, 25) . Taking a different approach, we designed an epicardium-like device that alleviates wall stress by integrating with the host myocardium. Owing to the low elastic modulus of the entire patterned system, the conformal surface contact on the moving heart could be achieved, minimizing the impedance between the mesh electrode and the heart surface (9, 26, 27) and increasing the adhesion to the heart (27) . Thus, the mesh recorded ECGs with a high signal-to-noise ratio and stimulated the heart with low threshold current even under cardiac motion.
The customized design of the epicardial mesh allowed adjustable electrical/mechanical properties to the specific heart size and shape. In the past, cardiac support devices, such as a woven polyester jacket and a nitinol mesh placed around the heart, were used in patients with severe heart failure. These clinical studies demonstrated prevention of further dilatation of the LV, promotion of reverse cardiac remodeling, and improvement in symptoms (6, 28) , which was likely attributable to reduced wall stress (29) . The epicardial serpentine mesh also showed a beneficial effect to reduce wall stress in a postinfarct rat heart without worsening diastolic function.
The current study has several limitations. We evaluated the acute response to electromechanical cardioplasty and did not assess longterm effects, mainly because of the large size of the pulse generator in comparison with the whole body of a rat. Although we identified a remarkably beneficial effect on systolic function by electromechanical cardioplasty, long-term response cannot be assured. The correlation of acute changes in dP/dt max with long-term response to cardiac resynchronization therapy has been controversial in clinical data (30) . Long-term beneficial and adverse effects should be performed in the future. Electromechanical cardioplasty was designed to simultaneously activate the entire epicardium of each ventricle through electrical flow from large dipoles on each side of the LV and RV. Because electrical flow may interact with the blood pool in the ventricular cavities with unknown consequences, it is possible that a version that activates the ventricles using a large number of individual electrical channels in a manner similar to endocardial activation by the Purkinje network may be superior (31) . Last, epicardial mesh pacing in this experiment was performed without AV synchronization owing to technical difficulty specific to the size of rats. The epicardial mesh pacing without AV synchronization, however, was superior to the baseline or atrial pacing with AV synchronization in post-MI rats, implying that VV synchronization has a much bigger effect on improving hemodynamics than AV synchronization. However, the effort to optimize synchronous contraction of atria and ventricles should be made in clinical application, which is expected to bring better improvement in cardiac hemodynamics.
Our organ-specific therapeutic device with a structure/functioninspired design can extend its application to various cardiac diseases including sinus node dysfunction and cardiac conduction disease. This technology is expected to be a solid basis for new attempts toward electrical modulation therapy to improve systolic function (32) , lowenergy defibrillators as alternatives to the painful defibrillator systems (33) , or other novel electrical therapies. Furthermore, it could accelerate advanced applications of organ-specific devices integrated with drug delivery system and cardiac tissue engineering. The next step should be to recreate these results in a large-animal model of MIinduced heart failure and evaluate for long-term performance.
MATERIALS AND METHODS

Study design
The aim of this study was to develop electromechanical cardioplasty by wrapping the epicardial surface of the heart in a mesh made of a nanocomposite of LE-AgNW/SBS. The device was designed to have an elastic modulus identical to that of the myocardium. Computer simulations estimated the effect of the epicardial mesh on cardiac hemodynamics. For in vivo experiments, rats were randomly assigned to control and MI groups. Treatment conditions were blinded during all experimental processes. On the basis of our previous experiences with the post-MI model, group sizes were determined; at least six rats were required to identify scar formation at 8 weeks after infarction because mortality is about 50% during an 8-week follow-up period. At 8 weeks after infarction, we evaluated the effect of electrical stimulation with the epicardial mesh device on total ventricular activation time, left ventricular function, myocardial wall stress, and LV pressure.
Large-scale synthesis and ligand exchange reaction of AgNW To synthesize AgNW, a modified CuCl 2 -mediated polyol process was used (34) . Eight hundred microliters of 4 mM copper chloride solution (CuCl 2 ·2H 2 O, 99%; Strem Chemicals Inc.) was added to 130 ml of 0.034 M PVP (average molecular weight, 55,000; Aldrich) solution in an oil bath (153°C), and then 30 ml of 0.094 M silver nitrate (AgNO 3 , >99% purity, Strem Chemicals Inc.) in ethylene glycol solution was injected into the reaction mixture. The synthesis reaction lasted for 1 hour. The reaction solution was diluted with acetone and centrifuged at 2000 rpm for 10 min. This centrifugation procedure was repeated twice. Next, 0.3 g of synthesized AgNW was dispersed in 54 ml of dimethylformamide (DMF), and 6 ml of 0.1 M NOBF 4 in DMF was added to the AgNW solution. After 5 min of gentle shaking, hexylamine in hexane (HAm) was added to the reaction solution. The synthesized LE-AgNW solution was diluted with ethanol and centrifuged at 2000 rpm. The LE-AgNW was dispersed in 6 ml of toluene.
Fabrication of the mesh electrode LE-AgNW/SBS (Kumho KTR-101, Kumho Petrochemical) solution was poured on the serpentine-shaped PDMS mold. The remaining solution on the top of the mold was removed with a blade. The molded solution was dried slowly at 45°C. The LE-AgNW/SBS solution was applied selectively on the bottom of PDMS mold to fabricate the epicardial mesh electrodes that are applied to the heart ( fig. S2 ). Additional SBS solution was poured in the mold to encapsulate the LE-AgNW/SBS layer.
Experimental MI animal model
All animal experiments were approved by the Committee for Care and Use of Laboratory Animals, Yonsei University College of Medicine, and performed in accordance with the Guidelines and Regulations for Animal Care. MI was produced in male Sprague-Dawley rats (320 to 430 g) by a permanent LAD ligation. Briefly, after anesthesia with ketamine (10 mg/kg) and xylazine (5 mg/kg), the hearts were exteriorized by opening the chest with sternotomy. Rats that expired during the procedure were excluded from mortality calculation. On the eighth week after permanent LAD ligation, rats were intubated and placed on a rodent ventilator (Hugo Sachs Elektronik-Harvard Apparatus, March-Hugstetten) under zoletil (20 mg/kg) and xylazine (5 mg/kg) anesthesia. Midsternotomy was then performed to expose the hearts, and the epicardial mesh was implanted.
Surface electrocardiography and electrophysiological studies Surface six-lead ECG (lead II is shown in figures) was continuously recorded along with all intracardiac electrograms and stored in the amplifier/recorder system (Pruka CardioLab IT System, GE Healthcare). The sampling rate was 4 kHz. R-R intervals, QRS durations, and QT intervals were measured as described previously (35, 36) . For the QTc interval measurement, Bazett's formula was used (37) . All parameters were measured twice by a cardiologist (H.J.H.) and a blinded investigator. The intraobserver variability was <10% for the cardiologists and electrophysiologists. Intracardiac electrograms were obtained from an epicardial mesh electrode and a 4F bipolar electrode catheter (2-mm interval; St. Jude Medical). Stimulation was performed at twice the pacing threshold of rectangular stimulus pulses with duration of 2 ms by a programmable digital stimulator (Bloom DTU 215, Fisher Medical Technologies) (average pacing threshold, 1.1 ± 0.2 mA). Ventricular tachycardia was defined as at least four ventricular beats and identified on the basis of atrioventricular dissociation on the intracardiac electrogram.
Statistical analysis
Data were expressed as means ± SEM for continuous variables and as proportions for categorical variables. For parametric variables, statistical analyses of pairs of groups and samples were conducted with paired and unpaired two-tailed Student's t test, respectively. A linear mixed model was used to account for repeated measurements in each group. In the linear mixed model, animals were included as random effects, and conditions (sinus rhythm, presence or absence of mesh), pacing (420, 320, and 280 ms), and interactions were treated as fixed effects.
Appropriate contrasts were selected to analyze differences between pacing levels and conditions. Differences in end-diastolic pressure, dP/dt max , and t values between groups at sinus rhythm and each pacing cycle length (420, 320, and 280 ms) were compared. The association between heart rates and QRS durations was analyzed using the Pearson correlation test. P < 0.05 was considered to represent a statistically significant difference. Statistical analysis was performed using the SPSS package for Windows (version 18.0; SPSS Inc). All statistical analyses were performed by two-sided tests.
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